Michael A. Zimmerman
( out of 13 reviews )

Michael A. Zimmerman, MD, FACS

Languages spoken: English

Clinical Locations

Primary Location

Primary Children's Hospital

100 N Mario Capecchi Drive
Salt Lake City , UT 84113
801-662-5566
Get Directions

Transplant Center

Transplant Center
50 N Medical Dr
Salt Lake City , UT 84132
801-581-2121
Get Directions
Show 1 more location(s)

University of Utah Hospital

Liver Transplant
50 N Medical Dr
Salt Lake City , UT 84132
801-581-2121
Get Directions

  • Michael A. Zimmerman, MD, is a transplant and hepatobiliary surgeon specializing in liver, kidney, and pancreas transplantation. His interests include clinical outcomes in solid organ abdominal transplant, and mitigating preservation and reperfusion injury in translational research.

    Dr. Zimmerman received his MD from the University of California at San Francisco and completed his residency at the University of Colorado. He completed fellowship training in Transplant and Hepatobiliary Surgery at the University of California Los Angeles. He has published over 100 peer-reviewed publications.

    Dr. Zimmerman's research focuses on the role of purinergic signaling and mitochondrial injury in liver ischemia-reperfusion injury.

    He currently serves as a professor of surgery in the Department of Surgery, Division of Transplant & Advanced Hepatobiliary Surgery at University of Utah Health. He is also the Director of the Adult kidney and pancreas transplant program, the director of the pediatric kidney transplant program at Primary Children's Hospital, and the Director of Transplant Research.

    Dr. Zimmerman's goal is to expand the donor pool using various organ resuscitation methods to increase the number of transplants available.

    In his spare time, Dr. Zimmerman enjoys Utah's mountains and skiing.

    Specialties

    Board Certification

    American Board of Surgery

    Patient Rating

    4.5 /5
    ( out of 13 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    UH HOSPITALS AND CLINICS

    Great doctor explains stuff really good

    UH HOSPITALS AND CLINICS

    He was very kind and took the time I needed to help me understand what to expect.

    UH HOSPITALS AND CLINICS

    The office visit with Dr. Zimmerman was extremely brief but he communicated pretty much all I needed to know.

    UH HOSPITALS AND CLINICS

    Dr. Zimmerman is a wonderful doctor and excellent surgeon. He has always taken time to answer my questions and put at ease any concerns I had, both before and following my surgery. He sincerely cares about his patients, and I know I can trust him completely to do his best. I highly recommend him!

    UH HOSPITALS AND CLINICS

    Down to earth, easy to talk to, on time for the appointment

    UH HOSPITALS AND CLINICS

    Dr. Zimmerman explained the surgery in a way that I could understand. He made me feel comfortable and confident going in to surgery.

    UH HOSPITALS AND CLINICS

    I highly recommend Dr Zimmerman!

    UH HOSPITALS AND CLINICS

    I am so grateful that Dr. Zimmerman is on my care team. He exudes confidence and helps me to understand my situation and feel better about my status. He did an amazing job on my surgery and I'm glad that he's also involved in the follow up care.

    UH HOSPITALS AND CLINICS

    We did not have any questions for Dr. Zimmerman since we know that the transplant surgery could potentially be years away, but he was very positive about [NAME REMOVED] and how he feels that [NAME REMOVED] will do during and following the surgery.

  • Michael A. Zimmerman, MD, is a transplant and hepatobiliary surgeon specializing in liver, kidney, and pancreas transplantation. His interests include clinical outcomes in solid organ abdominal transplant, and mitigating preservation and reperfusion injury in translational research.

    Dr. Zimmerman received his MD from the University of California at San Francisco and completed his residency at the University of Colorado. He completed fellowship training in Transplant and Hepatobiliary Surgery at the University of California Los Angeles. He has published over 100 peer-reviewed publications.

    Dr. Zimmerman's research focuses on the role of purinergic signaling and mitochondrial injury in liver ischemia-reperfusion injury.

    He currently serves as a professor of surgery in the Department of Surgery, Division of Transplant & Advanced Hepatobiliary Surgery at University of Utah Health. He is also the Director of the Adult kidney and pancreas transplant program, the director of the pediatric kidney transplant program at Primary Children's Hospital, and the Director of Transplant Research.

    Dr. Zimmerman's goal is to expand the donor pool using various organ resuscitation methods to increase the number of transplants available.

    In his spare time, Dr. Zimmerman enjoys Utah's mountains and skiing.

    Board Certification and Academic Information

    Academic Departments Surgery -Professor (Clinical)
    Academic Divisions Transplant & Advanced Hepatobiliary Surgery
    Board Certification
    American Board of Surgery

    Education history

    Undergraduate Functional Biology - California State University, Fresno B.A.
    Research Fellow Hematology/Oncology - University of California, San Francisco School of Medicine Research Fellow
    Professional Medical Medicine - University of California, San Francisco School of Medicine M.D.
    Internship General Surgery - University of Colorado School of Medicine Intern
    Residency General Surgery - University of Colorado School of Medicine Resident
    Fellowship Multi-organ Transplant - University of California, Los Angeles Fellow

    Selected Publications

    Journal Article

    1. Raeburn CD, Calkins CM, Zimmerman MA, Song Y, Ao L, Banerjee A, Meng X, Harken A (2001). Vascular cell adhesion molecule--1 expression is obligatory for endotoxin-induced myocardial neutrophil accumulation and contractile dysfunction. Surgery, 130(2), 319-25. (Read full publication)
    2. Raeburn CD, Calkins CM, Zimmerman MA, Song Y, Ao L, Banerjee A, Harken AH, Meng (2002). ICAM-1 and VCAM-1 mediate endotoxemic myocardial dysfunction independent of neutrophil accumulation. American journal of physiology. Regulatory, integrative and comparative physiology, 283(2), R477-86. (Read full publication)
    3. Zimmerman MA, Selzman CH, Reznikov LL, Raeburn CD, Barsness K, McIntyre RC Jr, Hamiel CR, Harken A (2002). Interleukin-11 attenuates human vascular smooth muscle cell proliferation. American journal of physiology. Heart and circulatory physiology, 283(1), H175-80. (Read full publication)
    4. Raeburn CD, Dinarello CA, Zimmerman MA, Calkins CM, Pomerantz BJ, McIntyre RC Jr, Harken AH, Meng (2002). Neutralization of IL-18 attenuates lipopolysaccharide-induced myocardial dysfunction. American journal of physiology. Heart and circulatory physiology, 283(2), H650-7. (Read full publication)
    5. Zimmerman MA, Selzman CH, Reznikov LL, Miller SA, Raeburn CD, Emmick J, Meng X, Harken A (2002). Lack of TNF-alpha attenuates intimal hyperplasia after mouse carotid artery injury. American journal of physiology. Regulatory, integrative and comparative physiology, 283(2), R505-12. (Read full publication)
    6. Selzman CH, Miller SA, Zimmerman MA, Gamboni-Robertson F, Harken AH, Banerjee (2002). Monocyte chemotactic protein-1 directly induces human vascular smooth muscle proliferation. American journal of physiology. Heart and circulatory physiology, 283(4), H1455-61. (Read full publication)
    7. Zimmerman MA, Reznikov LL, Sorensen AC, Selzman C (2003). Relative contribution of the TNF-alpha receptors to murine intimal hyperplasia. American journal of physiology. Regulatory, integrative and comparative physiology, 284(5), R1213-8. (Read full publication)
    8. Selzman CH, Netea MG, Zimmerman MA, Weinberg A, Reznikov LL, Grover FL, Dinarello C (2003). Atherogenic effects of Chlamydia pneumoniae: refuting the innocent bystander hypothesis. The Journal of thoracic and cardiovascular surgery, 126(3), 688-93. (Read full publication)
    9. Zimmerman MA, Reznikov LL, Raeburn CD, Selzman C (2004). Interleukin-10 attenuates the response to vascular injury. The Journal of surgical research, 121(2), 206-13. (Read full publication)
    10. Yersiz H, Cameron AM, Carmody I, Zimmerman MA, Kelly BS Jr, Ghobrial RM, Farmer DG, Busuttil R (2006). Split liver transplantation. Transplantation proceedings, 38(2), 602-3. (Read full publication)
    11. Cameron AM, Ghobrial RM, Hiatt JR, Carmody IC, Gordon SA, Farmer DG, Yersiz H, Zimmerman MA, Durazo F, Han SH, Saab S, Gornbein J, Busuttil R (2006). Effect of nonviral factors on hepatitis C recurrence after liver transplantation. Annals of surgery, 244(4), 563-71. (Read full publication)
    12. Zimmerman MA, Trotter JF, Wachs M, Bak T, Campsen J, Wright F, Steinberg T, Bennett W, Kam (2007). Predictors of long-term outcome following liver transplantation for hepatocellular carcinoma: a single-center experience. Transplant international, 20(9), 747-53. (Read full publication)
    13. Campsen J, Zimmerman MA, Trotter JF, Wachs M, Bak T, Steinberg T, Kam (2008). Clinically recurrent primary sclerosing cholangitis following liver transplantation: a time course. Liver transplantation, 14(2), 181-5. (Read full publication)
    14. Zimmerman MA, Ghobrial RM, Tong MJ, Hiatt JR, Cameron AM, Busuttil R (2007). Antiviral prophylaxis and recurrence of hepatocellular carcinoma following liver transplantation in patients with hepatitis B. Transplantation proceedings, 39(10), 3276-80. (Read full publication)
    15. Zimmerman MA, Trotter JF, Wachs M, Bak T, Campsen J, Skibba A, Kam (2008). Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma. Liver transplantation, 14(5), 633-8. (Read full publication)
    16. Campsen J, Zimmerman MA, Trotter JF, Wachs M, Bak T, Steinberg T, Kaplan M, Wright F, Kam (2008). Liver transplantation for autoimmune hepatitis and the success of aggressive corticosteroid withdrawal. Liver transplantation, 14(9), 1281-6. (Read full publication)
    17. Campsen J, Hendrickson RJ, Zimmerman MA, Wachs M, Bak T, Russ P, Bennet W, Trotter J, Kam (2008). Adult right lobe live donor liver transplantation without reconstruction of the middle hepatic vein: a single-center study of 109 cases. Transplantation, 85(5), 775-7. (Read full publication)
    18. Bennet W, Zimmerman MA, Campsen J, Mandell MS, Bak T, Wachs M, Kam (2009). Choledochoduodenostomy is a safe alternative to Roux-en-Y choledochojejunostomy for biliary reconstruction in liver transplantation. World journal of surgery, 33(5), 1022-5. (Read full publication)
    19. Campsen J, Zimmerman MA, Mandell MS, Wachs M, Bak T, Forman L, Steinberg T, Kam (2009). Hepaticoduodenostomy is an alternative to Roux-en-Y hepaticojejunostomy for biliary reconstruction in live donor liver transplantation. Transplantation, 87(12), 1842-5. (Read full publication)
    20. Halgrimson WR, Campsen J, Mandell MS, Kelly MA, Kam I, Zimmerman M (2010). Donor complications following laparoscopic compared to hand-assisted living donor nephrectomy: an analysis of the literature. Journal of transplantation, 2010, 825689. (Read full publication)
    21. Zimmerman MA, Kelly MA, Campsen J, Mandell MS, Wachs M, Bak T, Skibba A, Lancaster B, Kam (2010). The influence of OKT3 therapy on hepatocellular carcinoma recurrence following liver transplantation. Clinical transplantation, 24(4), E103-8. (Read full publication)
    22. Mengshol JA, Golden-Mason L, Arikawa T, Smith M, Niki T, McWilliams R, Randall JA, McMahan R, Zimmerman MA, Rangachari M, Dobrinskikh E, Busson P, Polyak SJ, Hirashima M, Rosen H (2010). A crucial role for Kupffer cell-derived galectin-9 in regulation of T cell immunity in hepatitis C infection. PloS one, 5(3), e9504. (Read full publication)
    23. Benson AB, Burton JR Jr, Austin GL, Biggins SW, Zimmerman MA, Kam I, Mandell S, Silliman CC, Rosen H, Moss (2011). Differential effects of plasma and red blood cell transfusions on acute lung injury and infection risk following liver transplantation. Liver transplantation, 17(2), 149-58. (Read full publication)
    24. Campsen J, Zimmerman MA, Mandell S, Kaplan M, Kam I (2011). A Decade of Experience Using mTor Inhibitors in Liver Transplantation. J Transplant, 2011, 913094. (Read full publication)
    25. Campsen J, Zimmerman MA, Narkewicz MR, Sokol RJ, Mandell MS, Kam I, Dovel D, Karrer FM (2011). Choledochoduodenostomy in pediatric liver transplantation. Pediatr Transplant, 15(3), 237-9. (Read full publication)
    26. Zimmerman MA, Haskins K, Bradley B, Gilman J, Gamboni-Robertson F, Flores SC (2011). Autoimmune-mediated vascular injury occurs prior to sustained hyperglycemia in a murine model of type I diabetes mellitus. J Surg Res, 168(2), e195-202. (Read full publication)
    27. Zimmerman MA, Baker T, Goodrich NP, Freise C, Hong JC, Kumer S, Abt P, Cotterell AH, Samstein B, Everhart JE, Merion RM (2013). Development, management, and resolution of biliary complications after living and deceased donor liver transplantation: a report from the adult-to-adult living donor liver transplantation cohort study consortium. Liver Transpl, 19(3), 259-67. (Read full publication)
    28. Tak E, Ridyard D, Badulak A, Giebler A, Shabeka U, Werner T, Clambey E, Moldovan R, Zimmerman MA, Eltzschig HK, Grenz A (2013). Protective role for netrin-1 during diabetic nephropathy. J Mol Med (Berl), 91(9), 1071-80. (Read full publication)
    29. Kelly MA, Kaplan M, Nydam T, Wachs M, Bak T, Kam I, Zimmerman M (2013). Sirolimus reduces the risk of significant hepatic fibrosis after liver transplantation for hepatitis C virus: a single-center experience. Transplantation proceedings, 45(9), 3325-8. (Read full publication)
    30. Samstein B, Smith AR, Freise CE, Zimmerman MA, Baker T, Olthoff KM, Fisher RA, Merion R (2016). Complications and Their Resolution in Recipients of Deceased and Living Donor Liver Transplants: Findings From the A2ALL Cohort Study. American journal of transplantation, 16(2), 594-602. (Read full publication)
    31. Chirichella TJ, Dunham CM, Zimmerman MA, Phelan EM, Mandell MS, Conzen KD, Kelley SE, Nydam TL, Bak TE, Kam I, Wachs M (2016). Donor preoperative oxygen delivery and post-extubation hypoxia impact donation after circulatory death hypoxic cholangiopathy. World journal of gastroenterology, 22(12), 3392-403. (Read full publication)
    32. Zimmerman MA, Selim M, Kim J, Regner K, Saeian K, Zanowski S, Martin A, Connolly LA, Lauer KK, Woehlck HJ, Hong J (2017). Outcome analysis of continuous intraoperative renal replacement therapy in the highest acuity liver transplant recipients: A single-center experience. Surgery, 161(5), 1279-1286. (Read full publication)
    33. Kim J, Kim T, Hong KS, Moon H, Oh IK, Lee SM, Hohenwalter MD, Zimmerman MA, Cronin DC, Hong JC (2017). Pre-Hepatectomy Assessment of Bile Transporter Expression by Gadoxetic Acid-Enhanced MRI in a Rat Model of Liver Cirrhosis. J Invest Surg, 30(4), 265-271. (Read full publication)
    34. Agopian VG, Harlander-Locke MP, Ruiz RM, Klintmalm GB, Senguttuvan S, Florman SS, Haydel B, Hoteit M, Levine MH, Lee DD, Taner CB, Verna EC, Halazun KJ, Abdelmessih R, Tevar AD, Humar A, Aucejo F, Chapman WC, Vachharajani N, Nguyen MH, Melcher ML, Nydam TL, Mobley C, Ghobrial RM, Amundsen B, Markmann JF, Langnas AN, Carney CA, Berumen J, Hemming AW, Sudan DL, Hong JC, Kim J, Zimmerman MA, Rana A, Kueht ML, Jones CM, Fishbein TM, Busuttil RW (2017). Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation: Analysis of 3601 Patients From the US Multicenter HCC Transplant Consortium. Ann Surg, 266(3), 525-535. (Read full publication)
    35. la Cour MF, Mehrvar S, Kim J, Martin A, Zimmerman MA, Hong JC, Ranji M (2017). Optical imaging for the assessment of hepatocyte metabolic state in ischemia and reperfusion injuries. Biomed Opt Express, 8(10), 4419-4426. (Read full publication)
    36. Baker TB, Zimmerman MA, Goodrich NP, Samstein B, Pomfret EA, Pomposelli JJ, Gillespie BW, Berg CL, Emond JC, Merion R (2017). Biliary reconstructive techniques and associated anatomic variants in adult living donor liver transplantations: The adult-to-adult living donor liver transplantation cohort study experience. Liver transplantation, 23(12), 1519-1530. (Read full publication)
    37. Zimmerman MA, Selim M, Kim J, Saeian K, Cinquegrani MP, Connolly L, Woehlck HJ, Lauer KK, Hong JC (2018). Impact of a Transplantation Critical Care Model on Short-Term Outcomes Following Liver Transplantation in High Acuity Patients: A Single-Center Experience. Transplant Proc, 50(10), 3544-3548. (Read full publication)
    38. Kim J, Zimmerman MA, Lerret SM, Scott JP, Voulgarelis S, Fons RA, Vitola BE, Telega GW, Hoffman GM, Berens RJ, Hong JC (2019). Staged biliary reconstruction after liver transplantation: A novel surgical strategy for high acuity pediatric transplant recipients. Surgery, 165(2), 323-328. (Read full publication)
    39. Kim J, Martin A, Yee J, Fojut L, Geurts AM, Oshima K, Zimmerman MA, Hong J (2019). Effects of Hepatic Ischemia-Reperfusion Injuries and NRF2 on Transcriptional Activities of Bile Transporters in Rats. The Journal of surgical research, 235, 73-82. (Read full publication)
    40. Pearson T, Zimmerman MA, Kim J, Palines PA, Eriksen CM, Wong M, Selim MA, Markovic D, Hong J (2019). Staged Biliary Reconstruction After Orthotopic Liver Transplantation: A Practical Surgical Strategy for High-Acuity Adult Recipients. Transplantation direct, 5(9), e482. (Read full publication)
    41. Wong M, Kim J, George B, Eriksen C, Pearson T, Robbins J, Zimmerman MA, Hong J (2019). Downstaging Locally Advanced Cholangiocarcinoma Pre-Liver Transplantation: A Prospective Pilot Study. The Journal of surgical research, 242, 23-30. (Read full publication)
    42. DiNorcia J, Florman SS, Haydel B, Tabrizian P, Ruiz RM, Klintmalm GB, Senguttuvan S, Lee DD, Taner CB, Verna EC, Halazun KJ, Hoteit M, Levine MH, Chapman WC, Vachharajani N, Aucejo F, Nguyen MH, Melcher ML, Tevar AD, Humar A, Mobley C, Ghobrial M, Nydam TL, Amundsen B, Markmann JF, Berumen J, Hemming AW, Langnas AN, Carney CA, Sudan DL, Hong JC, Kim J, Zimmerman MA, Rana A, Kueht ML, Jones CM, Fishbein TM, Markovic D, Busuttil RW, Agopian V (2020). Pathologic Response to Pretransplant Locoregional Therapy is Predictive of Patient Outcome After Liver Transplantation for Hepatocellular Carcinoma: Analysis From the US Multicenter HCC Transplant Consortium. Annals of surgery, 271(4), 616-624. (Read full publication)
    43. Roth AE, Marino IR, Ekwenna O, Dunn TB, Paloyo SR, Tan M, Correa-Rotter R, Kuhr CS, Marsh CL, Ortiz J, Testa G, Sindhwani P, Segev DL, Rogers J, Punch JD, Forbes RC, Zimmerman MA, Ellis MJ, Rege A, Basagoitia L, Krawiec KD, Rees M (2020). Global kidney exchange should expand wisely. Transplant international, 33(9), 985-988. (Read full publication)
    44. Kardashian A, Florman SS, Haydel B, Ruiz RM, Klintmalm GB, Lee DD, Taner CB, Aucejo F, Tevar AD, Humar A, Verna EC, Halazun KJ, Chapman WC, Vachharajani N, Hoteit M, Levine MH, Nguyen MH, Melcher ML, Langnas AN, Carney CA, Mobley C, Ghobrial M, Amundsen B, Markmann JF, Sudan DL, Jones CM, Berumen J, Hemming AW, Hong JC, Kim J, Zimmerman MA, Nydam TL, Rana A, Kueht ML, Fishbein TM, Markovic D, Busuttil RW, Agopian V (2020). Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients With Hepatocellular Carcinoma Presenting Beyond Milan Criteria. Hepatology (Baltimore, Md.), 72(6), 2014-2028. (Read full publication)
    45. Kim J, Zimmerman MA, Shin WY, Boettcher BT, Lee JS, Park JI, Ali M, Yang M, Mishra J, Hagen CE, McGraw JE, Mathison A, Woehlck HJ, Lomberk G, Camara AKS, Urrutia RA, Stowe DF, Hong J (2021). Effects of Subnormothermic Regulated Hepatic Reperfusion on Mitochondrial and Transcriptomic Profiles in a Porcine Model. Annals of surgery, (Read full publication)
    46. Kim J, Hagen CE, Kumar SN, Park JI, Zimmerman MA, Hong J (2020). Anticholestatic Effect of Bardoxolone Methyl on Hepatic Ischemia-reperfusion Injury in Rats. Transplantation direct, 6(8), e584. (Read full publication)
    47. Wong M, Narra R, Selim M, Zimmerman MA, Kim J, Padmanabhan A, Hong J (2020). Human Leukocyte Antigen Class I Antibodies and Response to Platelet Transfusion in Patients Undergoing Liver Transplantation. The Journal of surgical research, 255, 99-105. (Read full publication)
    48. Nair A, Coromina Hernandez L, Shah S, Zervos X, Zimmerman M, Sasaki K, Diago T, Hashimoto K, Fujiki M, Aucejo F, Bollinger J, Kaiser TL, Miller CM, Quintini C, Fung JJ, Eghtesad (2021). Induction Therapy With Antithymocyte Globulin and Delayed Calcineurin Inhibitor Initiation for Renal Protection in Liver Transplantation: A Multicenter Randomized Controlled Phase II-B Trial. Transplantation, (Read full publication)
    49. Zimmerman MA, Selim M, Kim J, Kozeniecki M, Hong JC (2018). A Specialized Transplantation Critical Care Model: Expanding Liver Transplantation Access to High-Acuity Patients. Transplant Proc, 50(9), 2619-2621. (Read full publication)
    50. Campsen J, Zimmerman M, Trotter J, Hong J, Freise C, Brown RS Jr, Cameron A, Ghobrial M, Kam I, Busuttil R, Saab S, Holt C, Emond JC, Stiles JB, Lukose T, Chang MS, Klintmalm G (2013). Multicenter review of liver transplant for hepatitis B-related liver disease: disparities in gender and ethnicity. Clin Transplant, 27(6), 829-37. (Read full publication)
    51. Campsen J, Zimmerman M, Trotter J, Hong J, Freise C, Brown R, Cameron A, Ghobrial M, Kam I, Busuttil R, Saab S, Holt C, Emond J, Stiles J, Lukose T, Chang M, Klintmalm G (2013). Liver transplantation for hepatitis B liver disease and concomitant hepatocellular carcinoma in the United States With hepatitis B immunoglobulin and nucleoside/nucleotide analogues. Liver Transpl, 19(9), 1020-9. (Read full publication)
    52. Tak E, Ridyard D, Kim JH, Zimmerman M, Werner T, Wang XX, Shabeka U, Seo SW, Christians U, Klawitter J, Moldovan R, Garcia G, Levi M, Haase V, Ravid K, Eltzschig HK, Grenz A (2014). CD73-dependent generation of adenosine and endothelial Adora2b signaling attenuate diabetic nephropathy. J Am Soc Nephrol, 25(3), 547-63. (Read full publication)
    53. Campsen J, Zimmerman M, Trotter J, Wachs M, Bak T, Steinberg T, Kaplan M, Kam I (2009). Liver transplantation for primary biliary cirrhosis: results of aggressive corticosteroid withdrawal. Transplant Proc, 41(5), 1707-12. (Read full publication)
    54. Jani A, Zimmerman M, Martin J, Lu L, Turkmen K, Ravichandran K, Pacic A, Ljubanovi¿ D, Edelstein C (2011). Perfusion storage reduces apoptosis in a porcine kidney model of donation after cardiac death. Transplantation, 91(2), 169-75. (Read full publication)
    55. Mandell MS, Campsen J, Zimmerman M, Biancofiore G, Tsou M (2009). The clinical value of early extubation. Current opinion in organ transplantation, 14(3), 297-302. (Read full publication)
    56. Cameron AM, Ghobrial RM, Yersiz H, Farmer DG, Lipshutz GS, Gordon SA, Zimmerman M, Hong J, Collins TE, Gornbein J, Amersi F, Weaver M, Cao C, Chen T, Hiatt JR, Busuttil R (2006). Optimal utilization of donor grafts with extended criteria: a single-center experience in over 1000 liver transplants. Annals of surgery, 243(6), 748-53; discussion 753-5. (Read full publication)
    57. Zimmerman M, Busuttil RW (2006). Long-term efficacy of percutaneous thermal ablation for patients with recurrent hepatocellular carcinoma. Nat Clin Pract Gastroenterol Hepatol, 3(5), 250-1. (Read full publication)
    58. Melnyk O, Zimmerman M, Kim KJ, Shuman M (1999). Neutralizing anti-vascular endothelial growth factor antibody inhibits further growth of established prostate cancer and metastases in a pre-clinical model. J Urol, 161(3), 960-3. (Read full publication)
    59. Zimmerman MA, Schiller J, Selim M, Kim J, Hong JC (2019). Management of renal failure in the liver transplant patient. Curr Transplant Rep.
    60. Hong JC, Kim J, Browning M, Wagner A, Lerret S, Segura AD, Zimmerman M (2017). Modified associating liver partition and portal vein ligation for staged hepatectomy for hepatoblastoma in a small infant: How far can we push the envelope?. Annals of surgery, 266, e16-17.
    61. Zimmerman MA, Busuttil R (2006). What is the long-term efficacy of thermal ablation for patients with recurrent hepatocellular carcinoma after hepatectomy?. Nature clinical practice. Gastroenterology & hepatology, 3, 251-2.
    62. Campsen J, Ray C, Zimmerman MA, Mandell MS, Kaplan M, Kam (2012). Diagnosis and correction of hepatic vena caval obstruction following liver transplantation. Indian Journal of Transplantation, 6, 1-4.
    63. Durazo FA, Nicholas AA, Mahaffey JJ, Sova S, Evans JJ, Kim J, Zimmerman MA, Hong J (2021). Post-COVID-19 cholangiopathy: A new indication for liver transplantation. Transplantation proceedings, 2021(53), 1132-1137.
    64. Kim J, Yang Y, Hong SK, Zielonka J, Dash RK, Audi SH, Kumar SN, Joshi A, Zimmerman MA, Hong J (2022). Fluorescein clearance kinetics in blood and bile indicates hepatic ischemia-reperfusion injury in rats. American journal of physiology. Gastrointestinal and liver physiology, (323), 126-133.
    65. Troung R, Moore HB, Sauaia A, Kam I, Pshak T, Adams M, Conzen K, Zimmerman MA, Wach M, Bak T, Pomposelli J, Pomfret E, Nydam T (2023). Choledochoduodenostomy continues to be a safe alternative for biliary reconstruction in deceased-donor liver transplantation. American journal of surgery, (9610), 663-338.
    66. SSarwal A, Yamauchi J, Raghavan D, MD, Shihab F, Fornadi K, Rofaiel G, Zimmerman M, Campsen J, Baker N, Yamini Akhila Ganireddy A, Aviles-Ovalle L, Baker T, Hall I, Molnar M (2023). Throwing Stones: Kidney Stone Incidence In Living Kidney Donor Candidates With Increased Metabolic Risk. Renal failure, 45(2226763),
    67. Yamauchi J, Raghavan J, Rofaiel G, Zimmerman M, Potluri VS, Baker T, Campsen J, Hall IE, Molnar M (2023). Therapeutic donor kidney transplant outcomes: Comparing early US experiences using optimal matching. Transplantation direct, 2, 1554.
    68. Yamauchi J, Azhar A, Hall IE, Bhalla A, Potluri VS, Tanriover B, Gupta G, Imlay H, Truax C, Balaraman V, Raghaven D, Zimmerman M, Campsen J, Rofaiel G, Baker T, Molnar M (2023). Comparison of Short-Term Outcomes in Kidney Transplant Recipients from SARS-CoV-2-Infected versus Noninfected Deceased Donors. Clinical journal of the American Society of Nephrology, 18, 1466-1475.
    69. Nwaduru C, Aviles Ovalle L, Hoareau GL, Baker E, Buff M, Selim M, Baker T, Zimmerman M (2024). Ectonucleotidases in Ischemia Reperfusion Injury: Unravelling the Interplay With Mitochondrial Dysfunction in Liver Transplantation. Transplantation proceedings, 56, 1598-1606.
    70. Nwaduru C, Baker E, Buff M, Selim M, Aviles Ovalle L, Baker T, Zimmerman M (2024). Assessing Liver Viability: Insights From Mitochondrial Bioenergetics in Ischemia-Reperfusion Injury. Transplantation proceedings, 56(4), 228-235.

    Review

    1. Zimmerman MA, Selzman CH, Harken A (1999). Surgical implications of therapeutic angiogenesis. Surgery, 125(3), 243-9. (Read full publication)
    2. Raeburn CD, Cleveland JC Jr, Zimmerman MA, Harken A (2001). Organ preconditioning. Archives of surgery (Chicago, Ill., 136(11), 1263-6. (Read full publication)
    3. Zimmerman MA, Selzman CH, Raeburn CD, Calkins CM, Barsness K, Harken A (2001). Clinical applications of cardiovascular angiogenesis. Journal of cardiac surgery, 16(6), 490-7. (Read full publication)
    4. Selzman CH, Miller SA, Zimmerman MA, Harken A (2001). The case for beta-adrenergic blockade as prophylaxis against perioperative cardiovascular morbidity and mortality. Archives of surgery (Chicago, Ill., 136(3), 286-90. (Read full publication)
    5. Albright TN, Zimmerman MA, Selzman C (2002). Vasopressin in the cardiac surgery intensive care unit. American journal of critical care, 11(4), 326-30; quiz 331-2. (Read full publication)
    6. Zimmerman MA, Albright TN, Raeburn CD, Selzman C (2002). Vasopressin in cardiovascular patients: therapeutic implications. Expert opinion on pharmacotherapy, 3(5), 505-12. (Read full publication)
    7. Raeburn CD, Calkins CM, Zimmerman MA, Arya J, Barsness KA, Harken A (2002). Toll-like receptors and surgical disease. Surgery, 131(5), 477-83. (Read full publication)
    8. Raeburn CD, Zimmerman MA, Arya J, Barsness K, Harken A (2002). Ischemic preconditioning: fact or fantasy?. Journal of cardiac surgery, 17(6), 536-42. (Read full publication)
    9. Raeburn CD, Zimmerman MA, Arya J, Banerjee A, Harken A (2002). Stem cells and myocardial repair. Journal of the American College of Surgeons, 195(5), 686-93. (Read full publication)
    10. Zimmerman MA, Selzman CH, Cothren C, Sorensen AC, Raeburn CD, Harken A (2003). Diagnostic implications of C-reactive protein. Archives of surgery (Chicago, Ill., 138(2), 220-4. (Read full publication)
    11. Zimmerman MA, Trotter J (2003). Living donor liver transplantation in patients with hepatitis C. Liver transplantation, 9(11), S52-7. (Read full publication)
    12. Raeburn CD, Zimmerman MA, Banerjee A, Cleveland CJ Jr, Harken A (2004). Surgical applications of organ preconditioning. Minerva chirurgica, 59(3), 209-18. (Read full publication)
    13. Zimmerman MA, Cameron AM, Ghobrial R (2006). Budd-Chiari syndrome. Clinics in liver disease, 10(2), 259-73, viii. (Read full publication)
    14. Zimmerman MA, Ghobrial R (2005). When shouldn't we retransplant?. Liver transplantation, (11 Suppl 2), S14-20. (Read full publication)
    15. Campsen J, Zimmerman MA, Trotter JF, Wachs M, Bak T, Mandell S, Kam (2007). Sirolimus and liver transplantation: clinical implications for hepatocellular carcinoma. Expert opinion on pharmacotherapy, 8(9), 1275-82. (Read full publication)
    16. Zimmerman MA, Ghobrial RM, Tong MJ, Hiatt JR, Cameron AM, Hong J, Busuttil R (2008). Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators. Archives of surgery (Chicago, Ill., 143(2), 182-8; discussion 188. (Read full publication)
    17. Zimmerman MA, Flores S (2009). Autoimmune-mediated oxidative stress and endothelial dysfunction: implications of accelerated vascular injury in type I diabetes. The Journal of surgical research, 155(1), 173-8. (Read full publication)
    18. Zimmerman MA, Kam I, Eltzschig H, Grenz (2013). Biological implications of extracellular adenosine in hepatic ischemia and reperfusion injury. American journal of transplantation, 13(10), 2524-9. (Read full publication)
    19. Kim J, Zimmerman M (2015). Technical aspects for live-donor organ procurement for liver, kidney, pancreas, and intestine. Current opinion in organ transplantation, 20(2), 133-9. (Read full publication)
    20. Zimmerman MA, Martin A, Hong J (2016). Basic considerations in organ perfusion physiology. Current opinion in organ transplantation, 21(3), 288-93. (Read full publication)
    21. Zimmerman MA, Schiller J, Kim J, Martin A, Selim M, Nydam TL, Cronin D 2nd, Hong J (2016). Pathologic sequelae of allosensitization in liver transplantation. The Journal of surgical research, 200(1), 195-9. (Read full publication)
    22. Zimmerman MA, Martin A, Yee J, Schiller J, Hong J (2017). Natural Killer T Cells in Liver Ischemia-Reperfusion Injury. Journal of clinical medicine, 6(4), (Read full publication)
    23. Kim J, Zimmerman MA, Hong J (2020). Liver transplantation in the treatment of unresectable hepatic metastasis from neuroendocrine tumors. Journal of gastrointestinal oncology, 11(3), 601-608. (Read full publication)
    24. Kim J, Zimmerman MA, Hong JC (2018). Emerging Innovations in Liver Preservation and Resuscitation. [Review]. Transplant Proc, 50, (8), 2308-2316. (Read full publication)
    25. Wedd JP, Nordstrom E, Nydam T, Durham J, Zimmerman M, Johnson T, Thomas Purcell W, Biggins SW (2015). Hepatocellular carcinoma in patients listed for liver transplantation: Current and future allocation policy and management strategies for the individual patient. [Review]. Liver Transpl, 21, (12), 1543-52. (Read full publication)
    26. Foster R, Zimmerman M, Trotter JF (2007). Expanding donor options: marginal, living, and split donors. [Review]. Clin Liver Dis, 11, (2), 417-29. (Read full publication)
    27. Nwaduru C, Ovalle LA, Hoareau GL, Baker E, Buff M, Selim M, Baker TB, Zimmerman M (2024). Ectonucleotidases in Ischemia Reperfusion Injury: Unravelling the Interplay With Mitochondrial Dysfunction in Liver Transplantation. Transplantation proceedings, 56(7), 1598-1606. (Read full publication)
    28. Perkins DD, Zimmerman M (1995). Empowerment theory, research, and application. American journal of community psychology, 23(5), 569-79. (Read full publication)

    Book Chapter

    1. Zimmerman MA, Cameron AM, Ghobrial R (2008). Hepatocellular carcinoma.
    2. Campsen J, Zimmerman MA, Bak (2009). Liver transplantation. 433-5.
    3. Campsen J, Zimmerman MA, Bak T (2009). Kidney and pancreas transplantation. 436-8.
    4. Zimmerman MA, Campsen (2010). Budd-Chiari Syndrome. 329-33.
    5. Zimmerman MA, Onaca N, Klintmalm G (2014). Novel immunosuppression of patients with hepatic malignancies.
    6. Zimmerman MA, Kam (2014). Choledochoduodenostomy.
    7. Zimmerman MA, Cameron AM, Ghobrial R Zimmerman MA, Cameron AM, Ghobrial RM. Hepatocellular carcinoma. Controversies in Liver Transplantation, 2008.
    8. Campsen J, Zimmerman MA, Bak T Campsen J, Zimmerman MA, Bak TE. Liver transplantation. Abernathy’s Surgical Secrets, 6th Edition. 2009;433-435.  .
    9. Campsen J, Zimmerman MA, Bak T Campsen J, Zimmerman MA, Bak TE. Kidney and pancreas transplantation. Abernathy’s Surgical Secrets, 6th Edition. 2009;436-438.
    10. Zimmerman MA, Campsen J Zimmerman MA, Campsen J. Budd-Chiari Syndrome. Current Surgical Therapy, 10th Edition. 2010, 329-333.
    11. Zimmerman MA, Onaca N, Klintmalm G Zimmerman MA, Onaca N, Klintmalm GB. Novel immunosuppression of patients with hepatic malignancies. Transplantation of the Liver, 3rd Edition, 20014. .
    12. Zimmerman MA, Kam I Zimmerman MA, Kam I. Choledochoduodenostomy. Operative Techniques in Transplant Surgery. Michael Mulholland, Daniel Albo, Michael Englesbe, Mary Hawn, Steven Highes, Michael Savel, 1st Edition, 2014.

    Case Report

    1. Selzman CH, Zimmerman MA, Campbell D (2003). ALCAPA in an adult with preserved left ventricular function. Journal of cardiac surgery, 18(1), 25-8. (Read full publication)
    2. Barbick B, Cothren CC, Zimmerman MA, Moore E (2005). Posttraumatic pneumatocele. Journal of the American College of Surgeons, 200(2), 306-7. (Read full publication)
    3. Cameron AM, Truty J, Truell J, Lassman C, Zimmerman MA, Kelly BS Jr, Farmer DG, Hiatt JR, Ghobrial R, Busuttil R (2005). Fulminant hepatic failure from primary hepatic lymphoma: successful treatment with orthotopic liver transplantation and chemotherapy. Transplantation, 80(7), 993-6. (Read full publication)
    4. Woehlck HJ, Boettcher BT, Lauer KK, Cronin DC, Hong JC, Zimmerman MA, Kim J, Selim (2016). Hydroxocobalamin for Vasoplegic Syndrome in Liver Transplantation: Restoration of Blood Pressure Without Vasospasm. A & A case reports, 7(12), 247-250. (Read full publication)
    5. Boettcher BT, Woehlck HJ, Reck SE, Hong JC, Zimmerman MA, Kim J, Zundel MT, Freed JK, Pagel PS (2017). Treatment of Vasoplegic Syndrome With Intravenous Hydroxocobalamin During Liver Transplantation. J Cardiothorac Vasc Anesth, 31(4), 1381-1384. (Read full publication)
    6. Hong JC, Kim J, Browning M, Wagner A, Lerret S, Segura AD, Zimmerman MA (2017). Modified Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy for Hepatoblastoma in a Small Infant: How Far Can We Push the Envelope? Ann Surg, 266(2), e16-e17. (Read full publication)
    7. Voulgarelis S, Hong JC, Zimmerman MA, Kim J, Scott J (2021). A novel escalation from veno-venous bypass to veno-venous ECMO during orthotopic liver transplantation. A case report. Perfusion, 36(8), 861-863. (Read full publication)
    8. Durazo FA, Nicholas AA, Mahaffey JJ, Sova S, Evans JJ, Trivella JP, Loy V, Kim J, Zimmerman MA, Hong J (2021). Post-Covid-19 Cholangiopathy-A New Indication for Liver Transplantation: A Case Report. Transplantation proceedings, 53(4), 1132-1137. (Read full publication)
    9. Kim J, Fons RA, Scott JP, Eriksen CM, Lerret SM, Browning MB, Telega GW, Vitola BE, Hoffman GM, North PE, Vo NN, Zimmerman MA, Hong JC (2018). Transabdominal Intrapericardial Approach in Liver Transplantation for Unresectable Primary Hepatic Functioning Paraganglioma With Invasion Into Hepatic Veins and Suprahepatic Vena Cava: A Surgical and Anesthesia Management Challenge. Transplant Proc, 50(9), 2630-2635. (Read full publication)
    10. Cheng SS, Berman GW, Merritt GR, Hendrickse A, Fiegel MJ, Teitelbaum I, Campsen J, Wachs M, Zimmerman M, Mandell M (2012). The response to methylene blue in patients with severe hypotension during liver transplantation. Journal of clinical anesthesia, 24(4), 324-8. (Read full publication)
    11. Campsen J, Zimmerman M, Shoen J, Wachs M, Bak T, Mandell MS, Kam (2008). Adjustable gastric banding in a morbidly obese patient during liver transplantation. Obesity surgery, 18(12), 1625-7. (Read full publication)

    Editorial

    1. Mandell MS, Zimmerman M, Campsen J, Kam (2008). Bariatric surgery in liver transplant patients: weighing the evidence. Obesity surgery, 18(12), 1515-6. (Read full publication)
    2. Mandell MS, Lindenfeld J, Tsou MY, Zimmerman (2008). Cardiac evaluation of liver transplant candidates. World journal of gastroenterology, 14(22), 3445-51. (Read full publication)

    Abstract

    1. Miller SA, Selzman CH, Pulido EJ, Zimmerman MA, Whitehill TA, Harken A (2000). Interleukin-10 (IL-10) attenuates the arterial inflammatory response to injury. Presented at the American College of Surgeons. 191, S72.
    2. Raeburn CD, Dinarello CA, Zimmerman MA, Calkins CM, Meng X, Harken A (2001). Neutralization of IL-18 protects cardiac function during endotoxemia with minimal effect on TNF. 100, 245.
    3. Zimmerman MA, Selzman CH, Raeburn CD, Hamiel C, Harken A (2001). Interleukin-11 attenuates human vascular smooth muscle cell proliferation. 100, 268.
    4. Zimmerman MA, Selzman CH, Reznikov LL, Miller SA, Raeburn CD, Emmick J, Meng X, Harken A (2001). TNFa is required for neointimal hyperplasia following mouse carotid injury. Presented at the American College of Surgeons. 25,
    5. Zimmerman MA, Selzman CH, Miller SA, Raeburn CD, Harken A (2001). TNFa is required for post-injury neointimal hyperplasia. (Supp II), 180.
    6. Zimmerman MA, Selzman CH, Dinarello C, Raeburn CD, Sorensen BS, Harken A (2002). Intimal hyperplasia requires adhesion molecule expression but not interleukin-1b. Presented at the American College of Surgeons. 195, S98.
    7. Gordon SA, Uchiyama K, McDiarmid SV, Datta S, Lipshutz G, Cameron AM, Carmdoy IC, Kelly B, Ruiz R, Zimmerman MA, Yersiz H, Farmer DG, Ghobrial RM, Busuttil R (2005). The effect of immunosuppression on ABO incompatible liver transplantation outcomes in the modern era. 11, C36.
    8. Zimmerman MA, Ghobrial RM, Cameron AM, Tong MJ, Busuttil R (2006). Antiviral prophylaxis and recurrence of hepatocellular carcinoma following liver transplantation in patients with hepatitis B. Presented at the American Transplant Congress. 830(supplement),
    9. Zimmerman, MA, Ghobrial RM, Klintmalm GB, Trotter JF, Cameron AM, Gornbein J, Farmer DG, Yersiz H, Busuttil R (2006). A short-term predictive model of survival following liver re-transplantation. Presented at the Liver Meeting.
    10. Campsen J, Zimmerman MA, Trotter JF, Wachs M, Bak T, Steinberg T, Kaplan M, Kam (2008). Recurrent primary biliary cirrhosis after liver transplantation at a center practicing corticosteroid minimization. Presented at the American Transplant Congress. 8(supplement 2), 286.
    11. Zimmerman MA, Trotter JF, Wachs M, Bak T, Campsen J, Kam (2008). Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma. Presented at the American Transplant Congress. 8(supplement 2), 470.
    12. Jani A, Lu L, Zimmerman MA, Ljubanovic D, Edelstein (2008). Caspase-3 activation in a porcine kidney model of extended criteria donation. Presented at the American Transplant Congress. 8(supplement 2), 428.
    13. Zimmerman MA, Flores S (2009). Autoimmune-mediated vascular injury in the setting of type I diabetes. Presented at the American Surigical Congress. 151, 266.
    14. Kaplan M, Kelly M, Wachs M, Bak T, Nydam T, Kam I, Zimmerman M (2010). Sirolimus- based immunosuppression has no influence on recurrent primary sclerosing cholangitis following orthotopic liver transplantation. Presented at the The Liver Meeting.
    15. Zimmerman MA, Kaplan M, Grenz A, Eltzschig (2011). Adenosine 2B receptor signaling in muring hepatic ischemia-reperfusion injury. Presented at the American Surgical Congress.
    16. Kelly, MA, Kaplan M, Smith M, Wachs M, Bak T, Kam, I, Zimmerman M (2011). Sirolimus reduces the risk of significant hepatic fibrosis and after liver transplantation for hepatitis C virus (HCV): a single center experience. Presented at the American College of Surgeons.
    17. Shaked A, Feng S, Punch J, Reyes J, Levitsky J, Klintmalm G, Zimmerman M, DesMarais M, Kopeskie H, Priore A, Bridges N, Sayre (2012). Initial Outcomes of ITN030ST: Early Post-liver Transplant Immunosuppression Withdrawal. Presented at the American Transplant Congress. 12(Suppl 3), 197.
    18. Campsen J, Zimmerman MA, Trotter J, Hong JC, Freise C, Brown R, Cameron AM, Ghobrial RM, Kam I, Busuttil RW, Saab S, Holt C, Emond J, Stiles J, Lukose T, Chang M, Klintmalm (2012). HBV reinfection after liver transplant is associated with increased recurrent hepatocellular carcinoma and worse survival. Presented at the American Transplant Congress. 12(Suppl 3), 199.
    19. Campsen J, Zimmerman MA, Trotter J, Hong JC, Freise C, Brown R, Cameron AM, Ghobrial RM, Kam I, Busuttil RW, Saab S, Holt C, Emond J, Stiles J, Lukose T, Chang M, Klintmalm (2012). Multicenter review of liver transplant for hepatitis B related liver disease: Females and black American do worse. Presented at the American Transplant Congress. 12(Suppl 3), 84.
    20. Zimmerman MA, Grenz A, Tak E, Kaplan M, Eltzschig (2012). Hepatocyte-specific protection by A2B adenosine receptors during ischemia-reperfusion injury of the liver. Presented at the American Society of Transplant Surgeons (ASTS) Winter Symposium.
    21. Zimmerman MA, Grenz A, Tak E, Kaplan M, Kam I, Eltzschig H (2013). Targeted inhibition of equilibrative nucleoside transporters protects during murine hepatic ischemia/reperfusion injury. Presented at the American Society of Transplant Surgeons (ASTS) Winter Symposium.
    22. Lin S, Ruller C, Gralla J, Kam I, Biggins SW, Zimmerman M, Lewis V, Nydam (2015). Improved renal function post-liver transplant with earlier everolimus (EVL) conversion. Presented at the American Transplant Congress.
    23. Selim M, Johnson C, Saad E, Zimmerman (2015). Optimal donor/recipient pairing for high KDPI grafts can yield similar survival to medium KDPI grafts. Presented at the American Society of Transplant Surgeons (ASTS) Winter Symposium.
    24. DiNorcia J, Florman SS, Haydel B, Ruiz RM, Klintmalm G, Senguttuvan S, Lee DD, Taner CB, Verna EC, Halazun KJ, Hoteit M, Levine MH, Chapman WC, Vachharajani N, Aucejo F, Nguyen MH, Melcher ML, Tevar AD, Humar A, Mobley C, Ghobrial MR, Nydam T, Amundsen B, Markmann JF, Berumen J, Hemming AW, Langnas AN, Carney CA, Sudan DL, Hong JC, Kim J, Zimmerman MA, Rana A, Khuet ML, Jones CM, Fishbein TM, Busuttil RW, Agopian V (2018). Pathologic Response to Pretransplant Locoregional Therapy is Predictive of Patient Outcome after Liver Transplantation for Hepatocellular Carcinoma: An Analysis from the US Multicenter HCC Transplant Consortium. Presented at the Pacific Coast Surgical Association 89th Annual Meeting, Napa, CA.
    25. Kim J, Martin A, Zimmerman MA, Hong J (2016). The effect of type and duration of hepatic ischemia on hepatocyte membrane bile transporter expression. Presented at the International Liver Transplant Society Congress, Seoul, Korea.
    26. 31. Kim J, North PE, Lerret SM, Bernadette VE, Telega GW, Zimmerman MA, Hong J (2016). Liver transplantation for non-resectable malignant hepatic paraganglioma: the first case report. Presented at the International Liver Transplant Society Congress, Seoul, Korea.
    27. Zimmerman MA, Baker T, Freise C, Hong JC, Kumer S, Abt P, Cotterell A, Goodrich NP, Merion R (2012). Aggregate morbidity and resolution of biliary complications after living donor and deceased donor liver transplantation: A report from the adult-to- adult living donor liver transplantation cohort study (A2ALL). Presented at the American Transplant Congress. 12(Suppl 3), 108.
    28. Grenz A, Tak E, Kaplan M, Kam I, Eltzschig HK, Zimmerman M (2014). Induction of CD39 and CD73 during human liver transplantation correlates to ischemic liver injury in knockout mice. Presented at the American Society of Transplant Surgeons (ASTS) Winter Symposium.
    29. Zimmerman MA, Selzman CH, Reznikov LL, Miller SA, Raeburn CD, Emmick J, Meng X, Harken A TNFa is required for neointimal hyperplasia following mouse carotid injury. Surg Forum, The American College of Surgeons, 2001;25.
    30. Gordon SA, Uchiyama K, McDiarmid SV, Datta S, Lipshutz G, Cameron AM, Carmdoy IC, Kelly B, Ruiz R, Zimmerman MA, Yersiz H, Farmer DG, Ghobrial RM, Busuttil R The effect of immunosuppression on ABO incompatible liver transplantation outcomes in the modern era. Liver Transpl. 2005;11:C36.
    31. Zimmerman MA, Ghobrial RM, Cameron AM, Tong MJ, Busuttil R Antiviral prophylaxis and recurrence of hepatocellular carcinoma following liver transplantation in patients with hepatitis B. Am J Transplant, American Transplant Congress, 2006;830:supplement.
    32. Zimmerman, MA, Ghobrial RM, Klintmalm GB, Trotter JF, Cameron AM, Gornbein J, Farmer DG, Yersiz H, Busuttil RW A short-term predictive model of survival following liver re-transplantation. Hepatology, The Liver Meeting 2006. .
    33. Zimmerman MA, Ghobrial R, Hong J, Trotter J, Cameron AM, Klintmalm G, Busuttil RW Zimmerman MA, Ghobrial R, Hong J, Trotter J, Cameron AM, Klintmalm G, Busuttil RW. An accurate model to predict survival following retransplantation. The Liver Meeting 2006. .
    34. Collins T, Ghobrial RM, Hong J, Cameron AM, Gornbein J, Zimmerman MA, Farmer DG, Yersiz H, Gordon RM, Lipshutz G, Busuttil RW Collins T, Ghobrial RM, Hong J, Cameron AM, Gornbein J, Zimmerman MA, Farmer DG, Yersiz H, Gordon RM, Lipshutz G, Busuttil RW. Recurrence risk score predicts cumulative increase in hepatitis C recurrence after liver transplantation. The Liver Meeting 2006.
    35. Campsen J, Zimmerman MA, Trotter JF, Wachs M, Bak T, Steinberg T, Kaplan M, Kam I Campsen J, Zimmerman MA, Trotter JF, Wachs M, Bak T, Steinberg T, Kaplan M, Kam I. Recurrent primary biliary cirrhosis after liver transplantation at a center practicing corticosteroid minimization. Am J Transpl, American Transplant Congress, 2008:8;286, supplement 2.
    36. Zimmerman MA, Trotter JF, Wachs M, Bak T, Campsen J, Kam I Zimmerman MA, Trotter JF, Wachs M, Bak T, Campsen J, Kam I. Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma. Am J Transpl, American Transplant Congress, 2008:8;470, supplement 2. .
    37. Zimmerman MA, Flores SC Zimmerman MA, Flores SC. Autoimmune-mediated vascular injury in the setting of type I diabetes. J Surg Res, American Surigical Congress, 2009:151;266.
    38. Walcher AM, Denned P, Jani A, Faubell S, Yalavarthy R, Keniston A, Altmann C, Zimmerman MA, Forman L, Roberts M, Devarajan P Walcher AM, Denned P, Jani A, Faubell S, Yalavarthy R, Keniston A, Altmann C, Zimmerman MA, Forman L, Roberts M, Devarajan P. Novel biomarkers of acute kidney injury in liver transplant patients. ASN, 2009.
    39. Kaplan M, Kelly M, Wachs M, Bak T, Nydam T, Kam I, Zimmerman M Kaplan M, Kelly M, Wachs M, Bak T, Nydam T, Kam I, Zimmerman MA. Sirolimus-based immunosuppression has no influence on recurrent primary sclerosing cholangitis following orthotopic liver transplantation. Hepatology, The Liver Meeting 2010.
    40. Zimmerman MA, Kaplan M, Grenz A, Eltzschig Zimmerman MA, Kaplan M, Grenz A, Eltzschig H. Adenosine 2B receptor signaling in muring hepatic ischemia-reperfusion injury. J Surg Res, American Surgical Congress, 2011.
    41. Kelly, MA, Kaplan M, Smith M, Wachs M, Bak T, Kam, I, Zimmerman MA Kelly, MA, Kaplan M, Smith M, Wachs M, Bak T, Kam, I, Zimmerman MA. Sirolimus reduces the risk of significant hepatic fibrosis and after liver transplantation for hepatitis C virus (HCV): a single center experience. Surgical Forum, The American College of Surgeons, J Am Coll Surg, 2011.
    42. A Shaked, S Feng, J Punch, J Reyes, J Levitsky, G Klintmalm, M Zimmerman, M DesMarais, H Kopeskie, A Priore, N Bridges, P Sayr A Shaked, S Feng, J Punch, J Reyes, J Levitsky, G Klintmalm, M Zimmerman, M DesMarais, H Kopeskie, A Priore, N Bridges, P Sayre. Initial Outcomes of ITN030ST: Early Post-liver Transplant Immunosuppression Withdrawal. Am J Transpl, American Transplant Congress, 2012:Suppl 3,12;197.
    43. Campsen J, Zimmerman MA, Trotter J, Hong JC, Freise C, Brown R, Cameron AM, Ghobrial RM, Kam I, Busuttil RW, Saab S, Holt C, Emond J, Stiles J, Lukose T, Chang M, Klintmalm G Campsen J, Zimmerman MA, Trotter J, Hong JC, Freise C, Brown R, Cameron AM, Ghobrial RM, Kam I, Busuttil RW, Saab S, Holt C, Emond J, Stiles J, Lukose T, Chang M, Klintmalm G. HBV reinfection after liver transplant is associated with increased recurrent hepatocellular carcinoma and worse survival. Am J Transpl, American Transplant Congress, 2012:Suppl 3, 12,199.
    44. Campsen J, Zimmerman MA, Trotter J, Hong JC, Freise C, Brown R, Cameron AM, Ghobrial RM, Kam I, Busuttil RW, Saab S, Holt C, Emond J, Stiles J, Lukose T, Chang M, Klintmalm G Campsen J, Zimmerman MA, Trotter J, Hong JC, Freise C, Brown R, Cameron AM, Ghobrial RM, Kam I, Busuttil RW, Saab S, Holt C, Emond J, Stiles J, Lukose T, Chang M, Klintmalm G. Multicenter review of liver transplant for hepatitis B related liver disease: Females and black American do worse. Am J Transpl, American Transplant Congress, 2012:Suppl 3,12;84.
    45. Zimmerman MA, Baker T, Freise C, Hong JC, Kumer S, Abt P, Cotterell A, Goodrich NP, Merion RM Zimmerman MA, Baker T, Freise C, Hong JC, Kumer S, Abt P, Cotterell A, Goodrich NP, Merion RM. Aggregate morbidity and resolution of biliary complications after living donor and deceased donor liver transplantation: A report from the adult-to-adult living donor liver transplantation cohort study (A2ALL). Am J Transpl, American Transplant Congress, 2012:Suppl 3, 12;108. .
    46. Zimmerman MA, Grenz A, Tak E, Kaplan M, Eltzschig H Zimmerman MA, Grenz A, Tak E, Kaplan M, Eltzschig H. Hepatocyte-specific protection by A2B adenosine receptors during ischemia-reperfusion injury of the liver. Am J Transpl, American Society of Transplant Surgeons (ASTS) Winter Symposium, 2012.
    47. Zimmerman MA, Grenz A, Tak E, Kaplan M, Kam I, Eltzschig HK Zimmerman MA, Grenz A, Tak E, Kaplan M, Kam I, Eltzschig HK. Targeted inhibition of equilibrative nucleoside transporters protects during murine hepatic ischemia/reperfusion injury. Am J Transpl, American Society of Transplant Surgeons (ASTS) Winter Symposium, 2013. .
    48. Pomposelli JJ, Humar A, Baker T, Grant D, Goodrich NP, Gillespie B, Merion RM, Kam I, Zimmerman MA, Samstein B,  Coterell A, Abt P, Freise C, Emond J and the A2ALL Study Group Pomposelli JJ, Humar A, Baker T, Grant D, Goodrich NP, Gillespie B, Merion RM, Kam I, Zimmerman MA, Samstein B,  Coterell A, Abt P, Freise C, Emond J and the A2ALL Study Group. “Small for Size Syndrome” (SFSS) after Living Donor Liver Transplantation (LDLT):  It’s Not About Size. Report from the Adult to Adult Living Donor Liver Transplantation (A2ALL) Cohort Study. AASLD, 2014.
    49. Grenz A, Tak E, Kaplan M, Kam I, Eltzschig HK, Zimmerman MA Grenz A, Tak E, Kaplan M, Kam I, Eltzschig HK, Zimmerman MA. Induction of CD39 and CD73 during human liver transplantation correlates to ischemic liver injury in knockout mice. Am J Transpl, American Society of Transplant Surgeons (ASTS) Winter Symposium, 2014.
    50. Lin S, Ruller C, Gralla J, Kam I, Biggins SW, Zimmerman M, Lewis V, Nydam T Lin S, Ruller C, Gralla J, Kam I, Biggins SW, Zimmerman M, Lewis V, Nydam T. Improved renal function post-liver transplant with earlier everolimus (EVL) conversion. Am J Transpl, American Transplant Congress, 2015. .
    51. Selim M, Johnson C, Saad E, Zimmerman M Selim M, Johnson C, Saad E, Zimmerman M. Optimal donor/recipient pairing for high KDPI grafts can yield similar survival to medium KDPI grafts. Am J Transpl, American Society of Transplant Surgeons (ASTS) Winter Symposium, 2015.
    52. Kim J, North PE, Lerret SM, Bernadette VE, Telega GW, Zimmerman MA, Hong JC Kim J, North PE, Lerret SM, Bernadette VE, Telega GW, Zimmerman MA, Hong JC. Liver transplantation for non-resectable malignant hepatic paraganglioma: the first case resport. Transplantation, International Liver Transplant Society 2016 Congress, Seoul, Korea.
    53. Kim J, Martin A, Zimmerman MA, Hong JC Kim J, Martin A, Zimmerman MA, Hong JC. The effect of type and duration of hepatic ischemia on hepatocyte membrane bile transporter expression. Transplantation, International Liver Transplant Society 2016 Congress, Seoul, Korea. .
    54. DiNorcia J, Florman SS, Haydel B, Ruiz RM, Klintmalm G, Senguttuvan S, Lee DD, Taner CB, Verna EC, Halazun KJ, Hoteit M, Levine MH, Chapman WC, Vachharajani N, Aucejo F, Nguyen MH, Melcher ML, Tevar AD, Humar A, Mobley C, Ghobrial MR, Nydam T, Amundsen B, Markmann JF, Berumen J, Hemming AW, Langnas AN, Carney CA, Sudan DL, Hong JC, Kim J, Zimmerman MA, Rana A, Khuet ML, Jones CM, Fishbein TM, Busuttil RW, Agopian V DiNorcia J, Florman SS, Haydel B, Ruiz RM, Klintmalm G, Senguttuvan S, Lee DD, Taner CB, Verna EC, Halazun KJ, Hoteit M, Levine MH, Chapman WC, Vachharajani N, Aucejo F, Nguyen MH, Melcher ML, Tevar AD, Humar A, Mobley C, Ghobrial MR, Nydam T, Amundsen B, Markmann JF, Berumen J, Hemming AW, Langnas AN, Carney CA, Sudan DL, Hong JC, Kim J, Zimmerman MA, Rana A, Khuet ML, Jones CM, Fishbein TM, Busuttil RW, Agopian VG. Pathologic Response to Pretransplant Locoregional Therapy is Predictive of Patient Outcome after Liver Transplantation for Hepatocellular Carcinoma: An Analysis from the US Multicenter HCC Transplant Consortium. JAMA Surgery, Pacific Coast Surgical Association 89th Annual Meeting, Napa, California, February 16-19, 2018.
    55. Kim J, Shin WY, Zimmerman MA, Martin A, Yee J, Hagen C, McGraw J, Camara A, Stowe D, Hong JC Kim J, Shin WY, Zimmerman MA, Martin A, Yee J, Hagen C, McGraw J, Camara A, Stowe D, Hong JC. Ex vivo subnormothermic regulated hepatic reperfusion is superior to normothermic machine perfusion: A novel concept of liver resuscitation after cardiac death in a large animal model. 13th World Congress of the international Hepato-Pancreato-Biliary Association, Geneva, Switzerland, September 4-7, 2018.
    56. Zimmerman MA, Kim J, Martin A, Fojut L, Lee J, Hong JC Zimmerman MA, Kim J, Martin A, Fojut L, Lee J, Hong JC. Uncoupling adaptive immune responses exacerbates hepatic ischemia-reperfusion injury. Academic Surgical Congress 2019, Houston, Texas.

    Video/Film/CD/Web/Podcast

    1. Zimmerman M, Tak E, Kaplan M, Mandell MS, Eltzschig HK, Grenz (2012). Use of a hanging-weight system for liver ischemia in mice. Journal of visualized experiments, (66), e2550. (Read full publication)

  • News & Podcasts

    News